Marimed (MRMD) Total Liabilities (2011 - 2026)

Marimed (MRMD) has 16 years of Total Liabilities data on file, last reported at $147.7 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $147.7 million, up 10.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $147.7 million (up 10.2% YoY), and the FY2025 annual result was $137.8 million, up 6.48% from the prior year.
• Total Liabilities improved to $147.7 million in Q1 2026 per MRMD's latest filing, from $137.8 million in the prior quarter.
• Over five years, Total Liabilities peaked at $147.7 million in Q1 2026 and troughed at $50.7 million in Q2 2022.
• A 5-year average of $103.7 million and a median of $113.5 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2025: Total Liabilities surged 87.54% in 2023, then advanced 6.48% in 2025.
• A 5-year view of Total Liabilities shows it stood at $57.2 million in 2022, then jumped by 87.54% to $107.2 million in 2023, then gained by 20.74% to $129.4 million in 2024, then climbed by 6.48% to $137.8 million in 2025, then rose by 7.19% to $147.7 million in 2026.
• Business Quant data shows MRMD's Total Liabilities at $147.7 million in Q1 2026, $137.8 million in Q4 2025, and $136.6 million in Q3 2025.